María Calvo-Arbeloa, Ana María Insausti-Serrano, Amaya Arrondo-Velasco, & María Teresa Sarobe-Carricas. (2020). Adherence to treatment with adalimumab, golimumab and ustekinumab in patients with inflammatory bowel disease. Elsevier.
Chicago Style (17th ed.) CitationMaría Calvo-Arbeloa, Ana María Insausti-Serrano, Amaya Arrondo-Velasco, and María Teresa Sarobe-Carricas. Adherence to Treatment with Adalimumab, Golimumab and Ustekinumab in Patients with Inflammatory Bowel Disease. Elsevier, 2020.
MLA (9th ed.) CitationMaría Calvo-Arbeloa, et al. Adherence to Treatment with Adalimumab, Golimumab and Ustekinumab in Patients with Inflammatory Bowel Disease. Elsevier, 2020.
Warning: These citations may not always be 100% accurate.